Julie Krop, SVP Clinical & Regulatory, CMO at AMAG PHARMACEUTICALS INC. (AMAG), sold 1,891 shares at $24.45 ($46K) on 2017-05-01, disclosed to the SEC on 2017-05-02.
Scheduled sale ($46k) by SVP Clinical & Regulatory, CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AMAG | SELL | 2017-07-14 | $99K | — | Filing → |
| AMAG | SELL | 2016-10-20 | $245K | — | Filing → |